Literature DB >> 7225939

The degradation of bradykinin (BK) and of des-Arg9-BK in plasma.

F Marceau, M Gendreau, J Barabé, S St-Pierre, D Regoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7225939     DOI： 10.1139/y81-022

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN： 0008-4212            Impact factor:   2.273


× No keyword cloud information.
  5 in total

1.  Cleavage of des-Arg9-bradykinin by angiotensin I-converting enzyme from pig kidney cortex.

Authors:  G Oshima; Y Hiraga; K Shirono; S Oh-ishi; S Sakakibara; T Kinoshita
Journal:  Experientia       Date:  1985-03-15

2.  Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.

Authors:  F Lembeck; T Griesbacher; M Eckhardt
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

Review 3.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 4.  The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.

Authors:  D F Emerich; R L Dean; C Osborn; R T Bartus
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation.

Authors:  T Griesbacher; F Lembeck; A Saria
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.